Aurora Cannabis Logs 3Q Profit, Revenue Tops Views

Dow Jones

Feb 05, 2025

By Adriano Marchese

Aurora Cannabis swung to a profit in its fiscal third-quarter thanks rise in the estimated value of its biological assets and strong medical cannabis revenue.

The Canadian cannabis company on Wednesday posted net income from continuing operations of 31.2 million Canadian dollars ($21.8 million) for the three months ended Dec. 31, compared with a loss of C$17.1 million in the prior-year period.

Aurora's profit includes an increase in unrealized gain on changes in fair value of biological assets of C$42.4 million, it said.

Adjusted earnings before interest, taxes, depreciation and amortization jumped to C$23.1 million from C$5.5 million.

Net revenues rose 37% to C$88.2 million, topping expectations of a rise to C$79.9 million, thanks to a 51% rise in medical cannabis and plant propagation revenue. Meanwhile, consumer cannabis net revenue continued its decline, falling 15%.

Looking ahead, Aurora expects continued revenue growth across its cannabis business, supported by strengthening international medical cannabis, while margins are expected support continued positive adjusted Ebitda.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

February 05, 2025 07:26 ET (12:26 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2509400981"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509400981\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509400981?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-05 20:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509400981","market":"sh","top_or_hot":-1,"title":"Aurora Cannabis Logs 3Q Profit, Revenue Tops Views","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre>\n \n</pre>\n<p>\n  Aurora Cannabis swung to a profit in its fiscal third-quarter thanks rise in the estimated value of its biological assets and strong medical cannabis revenue. \n</p>\n<p>\n  The Canadian cannabis company on Wednesday posted net income from continuing operations of 31.2 million Canadian dollars ($21.8 million) for the three months ended Dec. 31, compared with a loss of C$17.1 million in the prior-year period. \n</p>\n<p>\n  Aurora's profit includes an increase in unrealized gain on changes in fair value of biological assets of C$42.4 million, it said. \n</p>\n<p>\n  Adjusted earnings before interest, taxes, depreciation and amortization jumped to C$23.1 million from C$5.5 million. \n</p>\n<p>\n  Net revenues rose 37% to C$88.2 million, topping expectations of a rise to C$79.9 million, thanks to a 51% rise in medical cannabis and plant propagation revenue. Meanwhile, consumer cannabis net revenue continued its decline, falling 15%. \n</p>\n<p>\n  Looking ahead, Aurora expects continued revenue growth across its cannabis business, supported by strengthening international medical cannabis, while margins are expected support continued positive adjusted Ebitda. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 05, 2025 07:26 ET (12:26 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aurora Cannabis Logs 3Q Profit, Revenue Tops Views</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAurora Cannabis Logs 3Q Profit, Revenue Tops Views\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-05 20:26</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre>\n \n</pre>\n<p>\n  Aurora Cannabis swung to a profit in its fiscal third-quarter thanks rise in the estimated value of its biological assets and strong medical cannabis revenue. \n</p>\n<p>\n  The Canadian cannabis company on Wednesday posted net income from continuing operations of 31.2 million Canadian dollars ($21.8 million) for the three months ended Dec. 31, compared with a loss of C$17.1 million in the prior-year period. \n</p>\n<p>\n  Aurora's profit includes an increase in unrealized gain on changes in fair value of biological assets of C$42.4 million, it said. \n</p>\n<p>\n  Adjusted earnings before interest, taxes, depreciation and amortization jumped to C$23.1 million from C$5.5 million. \n</p>\n<p>\n  Net revenues rose 37% to C$88.2 million, topping expectations of a rise to C$79.9 million, thanks to a 51% rise in medical cannabis and plant propagation revenue. Meanwhile, consumer cannabis net revenue continued its decline, falling 15%. \n</p>\n<p>\n  Looking ahead, Aurora expects continued revenue growth across its cannabis business, supported by strengthening international medical cannabis, while margins are expected support continued positive adjusted Ebitda. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 05, 2025 07:26 ET (12:26 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACB","symbol_name":"奥罗拉大麻公司","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2509400981","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509400981","pubTimestamp":1738758360,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Aurora Cannabis swung to a profit in its fiscal third-quarter thanks rise in the estimated value of its biological assets and strong medical cannabis revenue.The Canadian cannabis company on Wednesday posted net income from continuing operations of 31.2 million Canadian dollars  for the three months ended Dec. 31, compared with a loss of C$17.1 million in the prior-year period.Aurora's profit includes an increase in unrealized gain on changes in fair value of biological assets of C$42.4 million, it said.Adjusted earnings before interest, taxes, depreciation and amortization jumped to C$23.1 million from C$5.5 million.Net revenues rose 37% to C$88.2 million, topping expectations of a rise to C$79.9 million, thanks to a 51% rise in medical cannabis and plant propagation revenue. Meanwhile, consumer cannabis net revenue continued its decline, falling 15%.Looking ahead, Aurora expects continued revenue growth across its cannabis business, supported by strengthening international medical ca","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ACB":"奥罗拉大麻公司"},"translate_title":"Aurora Cannabis第三季度盈利，收入位居浏览量榜首","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACB":1},"content_text":"By Adriano Marchese \n\n\n \n\n\n  Aurora Cannabis swung to a profit in its fiscal third-quarter thanks rise in the estimated value of its biological assets and strong medical cannabis revenue. \n\n\n  The Canadian cannabis company on Wednesday posted net income from continuing operations of 31.2 million Canadian dollars ($21.8 million) for the three months ended Dec. 31, compared with a loss of C$17.1 million in the prior-year period. \n\n\n  Aurora's profit includes an increase in unrealized gain on changes in fair value of biological assets of C$42.4 million, it said. \n\n\n  Adjusted earnings before interest, taxes, depreciation and amortization jumped to C$23.1 million from C$5.5 million. \n\n\n  Net revenues rose 37% to C$88.2 million, topping expectations of a rise to C$79.9 million, thanks to a 51% rise in medical cannabis and plant propagation revenue. Meanwhile, consumer cannabis net revenue continued its decline, falling 15%. \n\n\n  Looking ahead, Aurora expects continued revenue growth across its cannabis business, supported by strengthening international medical cannabis, while margins are expected support continued positive adjusted Ebitda. \n\n\n \n\n\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 05, 2025 07:26 ET (12:26 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}